• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从普通品牌香烟改用加热烟草制品或口含烟:第1部分。研究设计与方法。

Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 1. Study design and methodology.

作者信息

Ogden Michael W, Marano Kristin M, Jones Bobbette A, Stiles Mitchell F

机构信息

a RAI Services Company , Winston-Salem, NC , USA and.

b R.J. Reynolds Tobacco Company , Winston-Salem, NC , USA.

出版信息

Biomarkers. 2015;20(6-7):382-90. doi: 10.3109/1354750X.2015.1094133. Epub 2015 Nov 2.

DOI:10.3109/1354750X.2015.1094133
PMID:26525849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4720039/
Abstract

A randomized, multi-center study was conducted to assess potential improvement in health status measures, as well as changes in biomarkers of tobacco exposure and biomarkers of biological effect, in current adult cigarette smokers switched to tobacco-heating cigarettes, snus or ultra-low machine yield tobacco-burning cigarettes (50/group) evaluated over 24 weeks. Study design, conduct and methodology are presented here along with subjects' disposition, characteristics, compliance and safety results. This design and methodology, evaluating generally healthy adult smokers over a relatively short duration, proved feasible. Findings from this randomized study provide generalized knowledge of the risk continuum among various tobacco products (ClinicalTrials.gov Identifier: NCT02061917).

摘要

开展了一项随机、多中心研究,以评估转向吸加热烟草制品、口含烟或超低机台产量燃烧烟草制品(每组50人)的成年现吸烟者在24周内健康状况指标的潜在改善情况,以及烟草暴露生物标志物和生物学效应生物标志物的变化。本文介绍了研究设计、实施过程和方法,以及受试者的处置情况、特征、依从性和安全性结果。这种在相对较短时间内评估一般健康成年吸烟者的设计和方法被证明是可行的。这项随机研究的结果提供了关于各种烟草制品风险连续体的普遍知识(ClinicalTrials.gov标识符:NCT02061917)。

相似文献

1
Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 1. Study design and methodology.从普通品牌香烟改用加热烟草制品或口含烟:第1部分。研究设计与方法。
Biomarkers. 2015;20(6-7):382-90. doi: 10.3109/1354750X.2015.1094133. Epub 2015 Nov 2.
2
Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 2. Biomarkers of exposure.从普通品牌香烟改用加热烟草制品或口含烟:第2部分。暴露生物标志物。
Biomarkers. 2015;20(6-7):391-403. doi: 10.3109/1354750X.2015.1094134. Epub 2015 Nov 10.
3
Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 3. Biomarkers of biological effect.从普通品牌香烟改用加热烟草制品或口含烟:第3部分。生物学效应的生物标志物。
Biomarkers. 2015;20(6-7):404-10. doi: 10.3109/1354750X.2015.1094135. Epub 2015 Nov 2.
4
Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.随机试验比较鼻烟(含或不含无烟烟草健康信息)与尼古丁口含片的戒烟率。
Nicotine Tob Res. 2019 Jan 1;21(1):88-94. doi: 10.1093/ntr/nty011.
5
Association between willingness to use snus to quit smoking and perception of relative risk between snus and cigarettes.使用鼻烟戒烟的意愿与对鼻烟和香烟相对风险的认知之间的关联。
Nicotine Tob Res. 2012 Oct;14(10):1221-8. doi: 10.1093/ntr/nts077. Epub 2012 Mar 13.
6
Do never smokers make up an increasing share of snus users as cigarette smoking declines? Changes in smoking status among male snus users in Norway 2003-15.随着吸烟率下降,从不吸烟者在鼻烟使用者中所占比例是否在增加?2003 - 2015年挪威男性鼻烟使用者吸烟状况的变化。
Addiction. 2017 Feb;112(2):340-348. doi: 10.1111/add.13638. Epub 2016 Dec 5.
7
Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.对有意更换产品的吸烟者进行的鼻烟与药用尼古丁的随机临床试验。
Tob Control. 2016 May;25(3):267-74. doi: 10.1136/tobaccocontrol-2014-052080. Epub 2015 May 19.
8
Consumption patterns and biomarkers of exposure in cigarette smokers switched to Snus, various dissolvable tobacco products, Dual use, or tobacco abstinence.转向使用口含烟、各种可溶解烟草制品、双重使用或戒烟的吸烟者的消费模式和接触生物标志物。
Regul Toxicol Pharmacol. 2015 Mar;71(2):186-97. doi: 10.1016/j.yrtph.2014.12.016. Epub 2014 Dec 27.
9
A Randomized Clinical Trial of Snus Examining the Effect of Complete Versus Partial Cigarette Substitution on Smoking-Related Behaviors, and Biomarkers of Exposure.一项关于鼻烟的随机临床试验,研究了完全替代与部分替代香烟对吸烟相关行为和暴露生物标志物的影响。
Nicotine Tob Res. 2020 Apr 17;22(4):473-481. doi: 10.1093/ntr/ntz055.
10
Testing messages to reduce smokers' openness to using novel smokeless tobacco products.测试信息以降低吸烟者对使用新型无烟烟草产品的接受度。
Tob Control. 2014 Jul;23(4):313-21. doi: 10.1136/tobaccocontrol-2012-050723. Epub 2013 Mar 6.

引用本文的文献

1
Use of quantitative to extrapolation (QIVIVE) for the assessment of non-combustible next-generation product aerosols.使用定量外推法(QIVIVE)评估不可燃下一代产品气溶胶。
Front Toxicol. 2024 Apr 11;6:1373325. doi: 10.3389/ftox.2024.1373325. eCollection 2024.
2
Regulation of endothelial function by cigarette smoke and next-generation tobacco and nicotine products.香烟烟雾和新一代烟草及尼古丁产品对血管内皮功能的调节。
Pflugers Arch. 2023 Jul;475(7):835-844. doi: 10.1007/s00424-023-02824-w. Epub 2023 Jun 7.
3
Heated tobacco products for smoking cessation and reducing smoking prevalence.加热烟草制品戒烟和降低吸烟率。
Cochrane Database Syst Rev. 2022 Jan 6;1(1):CD013790. doi: 10.1002/14651858.CD013790.pub2.
4
Effects of Switching to the Tobacco Heating System 2.2 Menthol, Smoking Abstinence, or Continued Cigarette Smoking on Biomarkers of Exposure: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 1).在禁闭和门诊环境中连续进行的一项随机、对照、开放标签、多中心研究(第 1 部分):改用加热不燃烧系统 2.2 薄荷醇、戒烟或继续吸烟对暴露生物标志物的影响。
Nicotine Tob Res. 2018 Jan 5;20(2):161-172. doi: 10.1093/ntr/ntw287.
5
Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 2. Biomarkers of exposure.从普通品牌香烟改用加热烟草制品或口含烟:第2部分。暴露生物标志物。
Biomarkers. 2015;20(6-7):391-403. doi: 10.3109/1354750X.2015.1094134. Epub 2015 Nov 10.
6
Switching from usual brand cigarettes to a tobacco-heating cigarette or snus: Part 3. Biomarkers of biological effect.从普通品牌香烟改用加热烟草制品或口含烟:第3部分。生物学效应的生物标志物。
Biomarkers. 2015;20(6-7):404-10. doi: 10.3109/1354750X.2015.1094135. Epub 2015 Nov 2.

本文引用的文献

1
Estimating the harms of nicotine-containing products using the MCDA approach.使用多标准决策分析(MCDA)方法评估含尼古丁产品的危害。
Eur Addict Res. 2014;20(5):218-25. doi: 10.1159/000360220. Epub 2014 Apr 3.
2
The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007.无烟烟草制品的化学成分:2006 年和 2007 年美国市场销售产品的调查。
Regul Toxicol Pharmacol. 2012 Dec;64(3):367-87. doi: 10.1016/j.yrtph.2012.09.003. Epub 2012 Sep 19.
3
Vital signs: current cigarette smoking among adults aged ≥18 years--United States, 2005-2010.生命体征:2005-2010 年美国≥18 岁成年人中当前吸烟情况。
MMWR Morb Mortal Wkly Rep. 2011 Sep 9;60(35):1207-12.
4
The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US.美国烟草减害战略对话:愿景与行动蓝图
Tob Control. 2009 Aug;18(4):324-32. doi: 10.1136/tc.2008.027318. Epub 2009 Feb 24.
5
Medical participation in control of certain open-panel medical prepayment plans: Federal Trade Commission. Request for comment and advance notice of proposed rulemaking.医疗行业参与某些开放式医疗预付费计划的管控:联邦贸易委员会。征求意见及拟议规则制定预先通知。
Fed Regist. 1980 Mar 17;45(53):17019-24.
6
Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society.肺功能测试:参考值的选择与解读策略。美国胸科学会。
Am Rev Respir Dis. 1991 Nov;144(5):1202-18. doi: 10.1164/ajrccm/144.5.1202.
7
Epidemiology Standardization Project (American Thoracic Society).流行病学标准化项目(美国胸科学会)
Am Rev Respir Dis. 1978 Dec;118(6 Pt 2):1-120.